Cancer is a large group of diseases, which results in uncontrolled and rapid cell growth. Due to the uncontrolled growth of the cancer cells invade the surrounding healthy tissue and destroy it. Cancer usually starts in one part of the body, but can spread through the bloodstream and lymphatic system. There are more than 200 types of cancer that occur in humans, which all have different symptoms, depending on where they are located.
Brain cancer studies:
1) Anti-tumor effects of cannabidiol, a non-psychoactive cannabinoid, on human glioma cell lines (anti-tumor effects of cannabidiol, a cannabinoid Nonpsychoactive, on Human Glioma Cell Lines - 2003)
Under laboratory conditions, research has been conducted in order to investigate the hypothesis that CBD have anti-tumor properties. It was found that CBD is the viability of the tumor cells dropped significantly, suggesting that CBD is an effective antitumor agent. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) Neuroprotection by Δ9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain induced by excitotoxicity in the living organism (Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo excitotoxicity - 2001)
This research was designed to investigate the effects of THC on acute brain damage and brain degenerative diseases. It has been found that THC has an effect that protects the brain from degenerative diseases. Published in the "Journal of Neuroscience."
3) A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme (A pilot clinical study of Δ9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme - 2006)
This study was the first that was designed to explore the antitumor properties of cannabinoids in a clinical setting. She came to positive results, and it was found that THC and other cannabinoids inhibit tumor growth in patients. Published in the "British Journal of Cancer."
4) A combined preclinical therapy of cannabinoids and temozolomide against glioma (A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma - 2011)
This research aimed to evaluate the use of THC in conjunction with the drug TMZ in the treatment of glioblastoma multiforme - the most common and very resistant form of brain cancer. It has been found that the combined treatment showed that the reversed-tumor activity. Published in the journal "Molecular Cancer Therapeutics."
Breast cancer studies:
1) Anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma (anti-tumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma - 2006)
This research recognizes the antitumor effects of THC, but claims that it was problematic because of its psychoactive properties. Therefore, they went on to assess the effects of other cannabinoids. It was found that CBD showed promising anticarcinogenic characteristics that should be investigated further. Published in the "Journal of Pharmacology and Experimental Therapeutics."
2) pathways in mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion and metastasis (Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis - 2010)
This study was designed to determine the effects of CBD on breast cancer cells. It was found that it inhibited the growth and the spread of these cancer cells. It has also been discovered that CBD significantly reduced the tumor mass. Published in the "U.S. Library of Medicine."
3) Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition (Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition - 2010)
This research describes experiments that were performed to assess the effects of cannabinoids on the very aggressive ERB2-positive breast cancer. They concluded that cannabinoids both tumor growth, as well as the amount of existing tumors appeared to decrease, which strongly suggests that they represent a real application for the therapeutic treatment of breast cancer. Published in the journal "Molecular Cancer."
4) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation (The endogenous cannabinoid anandamide Inhibits human breast cancer cell proliferation - 1998)
This research was designed to investigate the effects of cannabinoids on the proliferation of breast cancer cells. It has been found to inhibit the growth. Published in the "National Academy of Sciences (PNAS)."
Lung cancer studies:
1) Δ9-Tetrahydrocannabinol inhibits both triggered by the epithelial growth factor lung cancer cell migration outside of the living organism, as well as the growth and metastasis in the living organism (Δ9-Tetrahydrocannabinol Inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo - 2008)
This research was conducted to study the effects of THC to the epithelial growth factor induced by cancer - a particularly aggressive and resistant to chemotherapy form of cancer. It was found that THC has played a significant role in inhibiting cancer growth, which justifies further research in this direction. Published in the journal "Oncogene."
2) Cannabidiol inhibits lung cancer cell invasion and metastasis via the intercellular adhesion molecule-1 (Cannabidiol Inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1-2011)
In this research, it was tried to examine the effects of CBD on the invasiveness of cancer. It has been found that cannabinoids inhibit the invasiveness of the primary tumor cells in patients with lung cancer. Published in the "U.S. National Library of Medicine."
3) The cannabinoid receptors CB1 and CB2 as new targets for the inhibition of large cell lung cancer growth and metastasis (cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis - 2011)
This research was conducted to determine the role of the cannabinoid receptor activation in lung cancer. It has been found that both inhibit the growth of cancer cells and enhance their apoptosis - the natural process of cell death. Published in the "U.S. National Library of Medicine."
Prostate cancer studies:
1) Anti-proliferative and apoptotic effects of anandamide in human Prostatakrebszellinien: implication of the reduction of epidermal growth factor receptors and ceramide production (anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production - 2003)
This study describes how the activation of cannabinoid receptors causes an antiproliferative effect in cancer cells in the prostate, which has major implications for the treatment of prostate cancer. Published in the "U.S. National Library of Medicine."
2) The role of cannabinoids in prostate cancer: basic scientific point of view and possible clinical applications (The role of cannabinoids in prostate cancer: Basic science perspective and potential clinical applications - 2012)
This study conducted a multi-evaluation of many other previous research on prostate cancer to determine whether cannabinoids have a practical clinical application. It has been found that it is in everyone's best interest to conduct clinical trials of medical cannabis. Published in the "U.S. National Library of Medicine."
3) Non-THC Cannabinoids inhibit prostate cancer growth in vitro and in vivo: Pro-apoptotic effects and the underlying mechanisms (non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms - 2013)
This research was designed to extend the previously explored idea that cannabinoid receptor activation causes cell death in prostate cancer cells. The research found significant positive results and found that the data supported the clinical tests of CBD from prostate cancer patients. Published in the "U.S. National Library of Medicine."
Blood cancer studies:
1) cannabinoid receptor-mediated apoptosis induced by R (+)-methanandamide and WIN55 0.212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma (Cannabinoid Receptor-Mediated Apoptosis Induced by R (+)-Methanandamide and WIN55, 212 - 2 Is Associated with Ceramide Accumulation and p38 Activation in Mantle Cell Lymphoma - 2006)
This research was designed to explore whether cannabinoids inhibit cancer cells in lymphomas. It describes that it has been found that cannabinoids inhibit the growth and induce cell death in mantle cell lymphoma (blood cancer). Published in the journal "Molecular Pharmacology."
2) triggered by Δ9-tetrahydrocannabinol apoptosis in Jurkat T-leukemia cells is regulated by the translocation of BAD mitochondria. (Δ9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria - 2006)
This research discusses how the use of cannabinoids in apoptosis (regulated and the natural death of cells) is to be evaluated. They yielded positive results, and it was found that cannabinoids actually cause the death of carcinogenic leukemia cells. Published in the "U.S. National Library of Medicine."
3) Activation of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activation (expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation - 2008)
This research aimed to determine the effects of the cannabinoid receptor activation on lymphomas. It has been found that the cannabinoid receptor activation, the multiplication and growth of lymphoma reduced, and causes the death of some cancer cells. Published in "International Journal of Cancer."
Oral cancer studies:
Cannabinoids inhibit cellular respiration of human oral cancer cells (Cannabinoids inhibit cellular respiration of human oral cancer cells - 2010)
This research was aimed to investigate the effects of cannabinoids on cell respiration in certain types of oral cancer. It has been found that cannabinoids inhibit cancer cell respiration and therefore have a toxic effect on them. This implies that cannabinoids may be used for the treatment of oral cancer. Published in the "U.S. National Library of Medicine."
Liver cancer studies:
Anti-tumor effect of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy (Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy - 2011)
This research aimed to determine what the effects of THC on cancer cells in the liver. It has been found that the growth of THC and the effectiveness of these cancer cells is reduced, which means that THC should be further examined as a therapeutic treatment. Published in the "U.S. National Library of Medicine."
Pancreatic cancer studies:
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes (Cannabinoids Induce Apoptosis of Pancreatic Tumor Cells via Endoplasmic Reticulum Stress-Related Genes - 2006)
This study suggests that pancreatic tumor tissue seems to have a much higher number of cannabinoid receptors compared to normal pancreatic tissues. The study found that, when the cannabinoids are administered to cancer cells began to die by apoptosis, resulting in a reduction in the growth and spread of the tumor. Published in "The American Journal of Cancer."
Chronic pain is pain that persists for more than 6 months. They are often a symptom of an underlying disease, such as cancer and multiple sclerosis, but can also be caused by a simple injury or infection. Chronic pain can take many forms, be it mild or excruciating and has in those affected usually a slow emotional impact. Prescribed drugs can often be ineffective or have undesirable side effects, so the effect of cannabis has been explored as a pain reliever.
Studies in this area:
1) Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, clinical cross-over study (Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial - 2008)
This study was conducted to determine how effectively acts cannabis in the treatment of chronic pain caused by nerve, caused by HIV. Here it was found that participants reported with the use of cannabis from a better pain relief than those who were given a placebo and that it was most effective when it was used in conjunction with other pain relieving therapies. Published in the journal "Neuropsychopharmacology."
2) Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia by in healthy volunteers (Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers - 2007)
Researchers conducted this study to examine how smoking cannabis would affect the perception of pain in patients induced with capsaicin pain suffered (the compound in chili peppers that causes a burning sensation when it comes in contact with tissue). They found that those who smoked a mean dose reported a significant reduction in pain, while those who smoked a higher dose, reported a significant increase in the induced pain. Published in the journal "Anesthesiology."
3) cannabinoids for the treatment of chronic pain that is not caused by tumors, a systematic review of randomized trials. (Cannabinoids for treatment of chronic non-cancer pain, a systematic review of randomized trials - 2011)
This study aimed to demonstrate the limited options that are available for those who suffer from chronic pain. They introduced random studies that compared the cannabis with a placebo and their effect on pain. It has been found that the use, cannabis, compared to those with a placebo, reported a significant pain reduction. Moreover, it has been found that the use of triggered no serious side effects. In summary, it was found that cannabinoids appear to be an effective and safe way to treat pain. Published in the "U.S. National Library of Medicine."
Cannabis Research: Diabetes
Diabetes mellitus is a group of diseases that is most commonly associated with a lack of insulin production, causing the blood sugar level is regulated wrong. There are two main types of diabetes, type 1 diabetes and type 2 diabetes. Patients who suffer from Type 1 diabetes, can ever produce no own natural insulin and are dependent on medication to survive. Type 2 diabetes patients do not produce enough insulin to support their body. This is a less severe form and can often be controlled with a strict diet. Untreated diabetes can lead to kidney failure, blindness, amputations and death.
To this end, studies carried out:
1) Cannabinoids block tactile allodynia in diabetic mice without attenuation of its antinociceptive effect. (Cannabinoids blocks tactile allodynia in diabetic mice without attenuation of its antinociceptive effect - 2004)
Caused by diabetes nerve pain is one of the most common causes of chronic pain. However, diabetics are less sensitive to the effects of analgesic drugs such as morphine and other opiates. This leaves the sufferer few options. This study was designed to assess the efficacy of cannabinoids in treating this type of pain. Through testing on diabetic mice found that cannabinoids may have a positive effect on pain reduction. Published in the "U.S. National Library of Medicine."
2) Cannabidiol lowers incidence of diabetes in non-obese diabetic mice (cannabidiol Lowers incidence of diabetes in non-obese diabetic mice - 2006)
This study was aimed to find out whether the cannabinoid CBD has an effect on the rate of diabetes-prone mice occurs in type 1 diabetes. It has been found that the onset of diabetes from a baseline of 86% in an untreated group to 30% in a group of mice treated with CBD, decreased. Published in "IngentaConnect."
3) Neuroprotective and blood-retinal barrier protective effects of cannabidiol in experimental diabetes. (Neuroprotective and Blood-Retinal Barrier-Preserving Effects if cannabidiol in experimental Diabetes2006)
This study examines how the non-psychoactive cannabinoid CBD may be applied to reduce damage to the retina caused by diabetes. Here, it was found that CBD inflammation, neurotoxicity and blood-retina in diabetic animals reduced expiration, indicating that the drug may be used to prevent the diabetic retinopathy. Published in the "U.S. National Library of Medicine.
Cannabis Research: Epilepsy
Epilepsy is a neurological disorder that causes intense bursts of electrical energy within the brain. This causes a temporary but recurring disorder, how the brain works - which leads to an epileptic seizure. An epileptic seizure can, among many other symptoms, loss of consciousness, sensory disturbances and convulsions Run.
1) cannabidiol shows antiepileptiforme properties and counteracts Krämofen; in vitro and in vivo (cannabidiol displays Antipileptiform and antiseizure Properties In Vitro and In Vivo - 2010)
This research aimed to experimentally explore the wider effects of CBD on its anticonvulsant properties in animals and in isolated tissue. It was found that CBD and its effects on the CB1 receptors showed the potential to inhibit epileptiform activity in isolated tissue samples and to reduce the severity of seizures in living animals. Published in the "U.S. National Library of Medicine."
2) Cannabidivarin has an antispasmodic effect in mice and rats (Cannabidivarin is anticonvulsant in mouse and rats - 2012)
This research was aimed to test the effect of the cannabinoid CBDV for cramps, such as those caused by epilepsy. It has been found that the use of such a cannabinoid effectively prevented convulsions and appeared to have no adverse effects on normal functions. Published in the "British Journal of Pharmacology."
3) Marijuana, Endocannabinoids and epilepsy: potentials and challenges for an improved therapeutic intervention (Marijuana, endocannabinoids, and epilepsy: potential and challenges for improved therapeutic intervention - 2013)
This research is a meta-study, which describes that the results of many other studies show apparently that cannabinoids and marijuana potentially beneficial for those act who suffer from neurological disorders such as epilepsy. Published in the "U.S. National Library of Medicine."
Cannabis Research: HIV
Human Immunodeficiency Virus (HIV) is a retrovirus that attacks the human immune system and the acquired immunodeficiency syndrome (AIDS) triggers - a disease that sets the immune system slowly overridden, so that those who are suffering from increasingly vulnerable to life-threatening disease be.
1) Marijuana as therapy for people living with HIV / AIDS: Social and health aspects (Marijuana as therapy for people living with HIV / AIDS: Social and health aspects - 2007)
This research aimed to evaluate the therapeutic use of cannabis in HIV patients. It was found that used as part of their treatments despite the many legal barriers, many marijuana affected by HIV and thus achieve a positive therapeutic effect. Published in the journal "AIDS Care:. Psychological and Socio-medical Aspects of AIDS / HIV"
2) dronabinol and cannabis in HIV-positive marijuana smokers: caloric intake, mood, and sleep (Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep - 2007)
This study confirms the count affected by HIV to one of the largest groups of medical marijuana users, but testified that no studies have been conducted to compare the effectiveness of oral use in this situation. It was found that in comparison to a placebo group, the group smoked cannabis, increased food intake had and was not affected by the noise. Published in the "Journal of Acquired Immune Deficiency Syndrome."
3) Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial (Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized, Placebo-Controlled Clinical Trial - 2003)
This study describes that marijuana could possibly have an influence on the use of other HIV drugs. The aim of the study was to determine whether the use of marijuana has any negative effects. It was found that the short-term use of marijuana apparently had no effect on the spread of the virus from the participant, suggesting that marijuana caused no adverse effect in combination with other medicines. Published in the "Annals of Internal Medicine."
Hashish and marijuana, the two most famous cannabis products, today the world's most consumed illegal drugs. Consumers see are usually not as addicts. Indeed a addictive nature of cannabis has been able to be clearly supported by any single scientific study.
Since prehistoric times hemp in Europe and Asia is used as a drug, remedies and fiber supplier. In the last 2000 years, the hemp widespread in Africa and has been incorporated in the culture of many indigenous tribes. After the discovery of America, hemp was by the conquerors in the New World.
The hemp could play an important role in today's medicine. So he may very well fight that occurs as a side effect of chemotherapy nausea for instance. Also in the Ayurvedic medicine and homeopathy he has found entrance.
Today, cannabis is banned almost worldwide. Objective scientific studies were not a decisive factor for the ban. Rather, it is to aspirations of the USA back in the 30s. The reasons for this were racist, power-political and economic motives. Not only possession and consumption of hemp products were criminalized by this ban, but also the cultivation. This was not only the production of medicines from cannabis illegal, but also its use as a source of fiber, which destroyed an entire industry.
Meanwhile, the use of cannabis in many countries will (again) be tolerated. The Medicinal Use of Cannabis, however, is still not legal. However, there are prescription drugs with synthetic or semi-synthetic cannabinoids, which are used in many countries. Their effect is however often experienced by consumers unpleasant than those of natural cannabis, such as hashish or marijuana.
This is, interestingly, not as standard practice moved as cannabis ingredient THC into the center, but the cannabidiol (CBD).
Tetrahydrocannabinol (THC) is always shown as the main active ingredient in cannabis. But cannabis contains 66 different cannabinoids with different modes of action.
For THC the therapeutic use in some situations is difficult by the intoxicating effect. In addition, do not reach all patients with a pure THC preparation - in Switzerland as dronabinol in trade - a satisfactory treatment outcome.
Unlike THC CBD developed no psychoactive “high.” effect.
On the contrary, according to recent studies, CBD should neutralize the psychoactive effect of the THC's or at least slow down. Moreover, it should also have a cancer and anti-inflammatory effect. Already known for some time was its anticonvulsant, anxiolytic, and nausea-relieving effect. In addition, CBD is only slightly toxic and has few side effects, emphasizes the pharmacist Rudolf cautery, a specialist in cannabis at the University of Bern.
For a long time the research around the use of cannabis in medicine, according to cautery has mainly focused on the active ingredient THC. Cannabinoids have been used primarily to treat neurological disorders such as multiple sclerosis or epilepsy, against the side effects of chemotherapy or for chronic pain. The discovery of the CBD and its potency of cannabis gave new impetus to international research, says branding iron. For the natural remedies cannabis thereby always open new research approaches, such as the application in breast cancer, or psychosis. Medicinalcannabis has become increasingly important in recent years.
One consequence of this cannabis research is the introduction of Sativex - a drug with a combination of THC and CBD, may contribute to relief of pain and discomfort in multiple sclerosis.
Cannabis Research: Fibromyalgia
Fibromyalgia is a chronic pain syndrome, in which the standard have proven painkiller largely ineffective. It causes pain, which spread throughout the body, but the exact cause is still unknown. From Fibromyalgia sufferers also suffer from exhaustion and empflindlichen points along the spine, shoulders and hips.
Studies in this area:
1) The use of cannabis in patients with fibromyalgia: effect on symptoms relief and health-related quality of life (Cannabis Use in Patients with Fibromyalgia: Effects on symptom relief and Health-Related Quality of Life - 2011)
The aim of this study was to determine whether the use of cannabis to relieve symptoms in patients with fibromyalgia contributes, as well as to improve their quality of life. It emerged that the participants who used cannabis reported a significant reduction in pain and stiffness, improved relaxation and increased wellbeing. Compared to a control group who used no cannabis, there was also a reported improvement of the mental health of users. Published in the "U.S. National Library of Medicine."
Cannabis Research: Urinary incontinence
Urinary incontinence is the loss of control of the bladder, usually due to weak muscles, inflammation or nerve damage. It is mostly related to MS or Parkinson's disease.
Studies in this area:
1) A preliminary controlled study to determine whether cannabis extracts of the whole plant to improve persistent neurogenic symptoms (A preliminary controlled study to deterministic mine Whether whole-plant cannabis extracts can Improve intractable neurogenic symptoms - 2003)
This research aimed to find out whether the use of cannabis extracts would improve symptoms of MS, such as urinary incontinence, pain and spasticity. It was found that the use of cannabis appeared to improve symptoms that would otherwise respond to any other treatments more. It was also noted that the medically undesirable psychedelic symptoms occurred, though, but they were well tolerated. Published in the "U.S. National Library of Medicine."
2) An open pilot study of cannabis extracts for bladder dysfunction in advanced multiple sclerosis (n open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis - 2004)
This study was designed to verify the personal opinions that marijuana can help alleviate symptoms of Harnwegproblemen that were caused by MS. It has been found that the use of marijuana reduced the number of incontinence episodes, and the precipitated amount. In addition, it was reported that patients tended to have less pain and spasticity and sleep improved. Published in the "Multiple Sclerosis Journal".
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.
Cannabis in Western medicine
"For cancer patients it comes as a side effect of chemotherapy often too great nausea and vomiting. Moreover, already alone the smell of food can be unbearable, so it only with great overcoming is possible many cancer patients ever receive food. Cannabis can soothing by its anti-emetic (nausea ) Effect reduce this nausea and passing through its appetizing effect to a desired weight gain. many countries THC are now (= dronabinol)-containing preparations such as the and the U.S. coming Marinol available as prescription drugs for patients. However, many patients believe that gerauchtest Cannabis works much better, which is due to the unique combination of active ingredients in the cannabis plant. However, this application is still illegal.
Also in AIDS therapy you can make the appetizing effect of cannabis advantage. In addition to therapy, it is namely often a lack of food intake, which weakens the body additionally. In addition, cannabis can distract the patient and bring a sentiment with positive attitude. Also glaucoma in which the intraocular pressure is greatly increased, which can lead to blindness can be treated with cannabis. Without surgical intervention, alone by smoking cannabis, the intraocular pressure can be lowered to normal values. For this effect is not the psychoactive THC responsible, but that hardly psychoactive substances CBN (cannabinol) and CBD (cannabidiol). Therefore, can be a therapeutic application with low-THC hemp products. Cannabis also has ataxia (movement coordinator) effect, as well as an antispasmodic, so Muscle relaxation, which makes it a good means for suppressing spasms, paralysis and convulsions, as they occur in multiple sclerosis. It can not cure the disease, but suppress the symptoms of the disease and facilitate the patient as his life. Asthma attacks can be stopped by a few traits of a joint often. Criticism here is the damage to the lungs, which of course plays an important role in asthma attacks. Remedy is here to create an inhaler that is being developed. Even a mild antibiotic effect has an ingredient that the CBD. Further acting antiepileptic cannabis, thereby epileptics while cannabis administration, the dose of medication can be reduced. Cannabis may also be used for the treatment of different pain, headache, migraine and menstrual cramps. Also in obstetrics Cannabis can be used as an alternative, as it can lead to an increased frequency of contraction of the uterus and hemostasis. In Africa and Asia, this application is used in folk medicine to this day.
THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FDA AND ARE NOT INTENDED TO DIAGNOSE, TREAT, OR CURE ANY DISEASE. ALWAYS CHECK WITH YOUR PHYSICIAN BEFORE STARTING A NEW DIETARY SUPPLEMENT PROGRAM.